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Abstract Engleromyces goetzii is a traditional medicinal mushroom that is widely used to treat infection, inflammation
and cancer in Tibet, Sichuan and Yunnan provinces of China. Two new trichothecenes, engleromycones A and B (1 and 2),
one new cuparane-type sesquiterpenoid named infuscol F (11), eight known trichothecene analogs, sambucinol (3),
3-deoxysambucinol (4), trichothecolone (5), trichodermol (6), 8-deoxytrichothecin (7), trichothecin (8), trichothecinol B
(9) and trichothecinol A (10), and one known cyclopentanoid sesquiterpene cyclonerodiol (12) were isolated from the
cultures of E. goetzii. The new compounds were elucidated through spectroscopic analyses. The anticancer effects of
trichothecenes 1–10 were examined in the HL-60, SMMC-7721, A549, MCF-7, and SW-480 human cancer cell lines using
an MTT assay. Trichothecinol A (10) significantly inhibited the growth of MCF-7 cells, with an IC50 value of 0.006 lM,
which was comparable to the cytotoxic activity of the positive control, paclitaxel, indicating that trichothecinol A (10)
represents a potential anticancer agent.
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1 Introduction
Mushrooms have been valued worldwide as edible and
medical provisions for thousands of years. Several mush-
rooms, such as Ganoderma lucidum, Hericium erinaceus
and Antrodia cinnamomea, have historically been used in
Asia for medicinal purposes [1, 2]. Engleromyces goetzii,
which belongs to the family Hypocreaceae, is a traditional
medicinal mushroom that is primarily distributed in Tibet,
Sichuan and Yunnan provinces. This fungus typically
grows on bamboo in high mountains, and it ripens during
the rainy season from July to August. Local residents can
purchase this fungus at the market and boil the fruiting
bodies in water to treat infection, inflammation and cancer
[3–5]. The positive curative effects of E. goetzii have
garnered interest regarding the chemical constituents of
this mushroom. Previous investigations on the fruiting
bodies of this fungus have led to the isolation of neoeng-
leromycin, cytochalasin D and 19,20-epoxycytochalasin D
[4, 6, 7]. However, the chemical constituents of the cultures
of this fungus have not been previously reported. There-
fore, we conducted an initial investigation on E. goetzii
cultures, which resulted in the isolation of two trichot-
hecenes (4 and 8). In previous studies, trichothecin (8)
exhibited promising anticancer activity [8].
Trichothecenes are a series of mycotoxins produced by
several fungi, with genera including Fusarium,
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Mycothecium, Trichoderma, Trichothecium, Stachybotrys
and Cephalosporium [9, 10]. These fungi typically infest
maize, oats, barley and wheat, producing trichothecenes [9].
Currently, more than 150 trichothecenes have been reported
[10]. Trichothecenes are an important source of contamina-
tion in food and feed [11, 12]. When contaminated food and
feed are ingested, trichothecenes initiate a wide range of
acute and chronic symptoms, including cardiovascular
lesions, hypotension, anemia and lymphoid necrosis [13,
14]. The effects of trichothecenes on eukaryotic cells include
the inhibition of protein, DNA and RNA synthesis, inhibition
of mitochondrial functions and cell division, and membrane
effects [14, 16]. Moreover, trichothecenes exhibit multiple
biological activities, such as antibiotic, antibacterial, anti-
viral and antitumor activities [14, 15].
To identify additional novel and potentially bioactive
secondary metabolites, the chemical constituents of E.
goetzii cultures were investigated by altering the culture
conditions of the fungus and increasing the fermentation
scale. This investigation led to the isolation and identifi-
cation of two new trichothecenes named engleromycones
A and B (1 and 2), one new cuparane-type sesquiterpenoid
named infuscol F (11) (Fig. 1), eight known trichothecene
analogs, sambucinol (3), 3-deoxysambucinol (4), trichoth-
ecolone (5), trichodermol (6), 8-deoxytrichothecin (7),
trichothecin (8), trichothecinol B (9) and trichothecinol A
(10), and one known cyclopentanoid sesquiterpene cy-
clonerodiol (12). The structures of the compounds were
elucidated based on spectroscopic analyses. Cytotoxicity
assays against the HL-60, SMMC-7721, A549, MCF-7 and
SW-480 human cancer cell lines indicated that compounds
1, 2, and 5–10 significantly reduced the viabilities of these
cells. In particular, trichothecinol A (10) exhibited the
strongest inhibitory effect on the growth of MCF-7 cells,
with an IC50 value of 0.006 lM, which was comparable to
the cytotoxic activity of the positive control, paclitaxel. An
analysis of the structure-cytotoxicity relationships of tri-
chothecenes 1–10 suggested that the 12,13-epoxide ring,
the hydroxyl group at C-3 and the –OCOCH=CHCH3
substituent at C-4 clearly enhance the cytotoxic activity.
This study describes the isolation and structure elucidation
of the isolates and the cytotoxic activities and structure–
cytotoxicity relationships of the trichothecenes.
2 Results and Discussion
2.1 Structure Elucidation
Compound 1 is a colorless oil and exhibited an [M ? Na]?
ion at m/z 371.1472 in positive HR ESI MS analysis, cor-
responding to the molecular formula C19H24O6 with 8 of
Fig. 1 Structures of compounds 1–12
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unsaturation. The 1H NMR spectrum of 1 exhibited four
methyl groups at dH 0.91 (3H, s), 1.08 (3H, s), 1.84 (3H, s)
and 2.14 (3H, dd, J = 7.2, 1.8 Hz) and three olefinic pro-
tons at dH 5.74 (1H, dd, J = 11.4, 1.8 Hz) and 6.40 (2H,
overlapped). A careful analysis of the 1H NMR signals at
dH 5.74 (1H, dd, J = 11.4, 1.8 Hz), 6.40 (1H, overlapped),
and 2.14 (3H, dd, J = 7.2, 1.8 Hz) and the 13C NMR
(DEPT) signals at dC 165.2 (s), 119.7 (d), 146.9 (d), and
15.4 (q) revealed a –OCOCH=CHCH3 substituent group.
The remaining NMR signals indicated three methyl groups,
three methylenes, three methines and six quaternary car-
bons, suggesting that 1 was a sesquiterpene. The 1H and
13C NMR spectral data of 1 were similar to those of lou-
kacinal A [17], which confirmed that 1 is a trichothecene.
However, there are certain differences, as follows: the
resonance of H-4 at dH 4.30 in loukacinal A is downshifted
to dH 5.32 in 1, suggesting that the hydroxyl at C-4 is
esterified. The methane at dH 5.32 (1H, dd, J = 7.7,
2.0 Hz) exhibited an HMBC correlation with the carbons at
dC 165.2, indicating that the –OCOCH=CHCH3 substituent
group is attached to C-4 (Fig. 2). In the ROSEY spectrum,
the observed cross peaks of H-2/H-13, H-13/CH3-14, and
H-4/CH3-15 suggested that H-2, H-13 and CH3-14 lie on
the same side, whereas H-4 and CH3-15 lie on the opposite
side (Fig. 2). Therefore, 1 was determined as engleromy-
cone A.
Compound 2 was obtained as a colorless oil with a
molecular formula of C19H24O4 based on the HR ESI MS ion
at m/z 339.1563 ([M ? Na]?), requiring 8 of unsaturation.
The 1D NMR spectroscopic data (Table 1) suggested that
the backbone of 2 was identical to that of 1. One of the
differences between these compounds was identified as the
loss of a quaternary carbon and the appearance of a methine.
In HMBC analysis (Fig. 3), the proton signal at dH 3.95
correlated with the carbons at dC 18.4, 79.3 and 138.0, sug-
gesting that the oxygen linkage between C-11 and C-12
disappeared, and a methine was present at C-11. Moreover,
the proton signals at dH 5.22 and 4.81 correlated with the
carbons at dC 79.3 and 51.7 (Fig. 3), indicating that a double
bond was formed between C-12 and C-13. In the ROSEY
spectrum, the observed cross peaks of H-4/H-11, H-11/CH3-
15, CH3-15/H-4, H-13a/CH3-14 and H-2/H-13b suggested
that H-4, H-11 and CH3-15 lie on the same side, whereas H-2,
H-13 and CH3-14 lie on the opposite side (Fig. 3). Therefore,
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Fig. 3 Selected 2D NMR correlations of 2
Table 1 1H NMR (500 MHz) and 13C NMR (125 MHz) data for
compounds 1 and 2 in CDCl3
1 2
dC type dH (J in Hz) dC type dH (J in Hz)
2 79.9, d 4.42, d (5.1) 79.3, d 4.54, d (5.2)





4 76.2, d 5.32, dd (7.7, 2.0) 73.4, d 5.54, dd (7.6, 3.5)
5 53.6, s 51.7, s
6 54.8, s 43.6, s
7 47.7, t 2.74, d (15.0) 41.6, t 2.79, d (16.0)
2.28, d (15.0) 2.20, d (16.0)
8 198.5, s 199.5, s
9 141.4, s 138.0, s
10 133.5, d 6.40, overlapped 137.3, d 6.47, dd (5.7, 1.4)
11 105.9, s 69.6, d 3.95, d (5.7)
12 96.7, s 151.5, s
13 58.6, t 4.10, d (12.5) 107.0, t 5.22, s, H-b
3.90, dd (12.5, 7.5) 4.81, s, H-a
14 10.9, q 0.91, s 10.0, q 0.93, s
15 17.4, q 1.08, s 18.4, q 1.05, s
16 15.4, q 1.84, s 15.5, q 1.78, s
10 165.2, s 165.9, s
20 119.7, d 5.74, dd (11.4, 1.8) 120.2, d 5.76, dd (11.4, 1.8)
30 146.9, d 6.40, overlapped 146.1, d 6.36, dq (11.4, 7.4)
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Compound 11 possessed the molecular formula C15H26O2
as determined by HR ESI MS analysis (m/z 261.1825
[M ? Na]?), which indicated 3 of unsaturation. The 1H
NMR spectrum indicated four methyl groups at dH 0.79 (3H,
s), 0.99 (3H, s), 1.02 (3H, s) and 1.13 (3H, s) and one olefinic
proton at dH 5.44 (1H, m). The
1H and 13C NMR spectra
indicated a trisubstituted double bond (dH 5.44, m; dC123.8,
d; and dC 146.0, s), an oxygen-bearing methine (dH 3.74, m;
dC 72.2, d), an oxygen-bearing quaternary carbon (dC 69.2),
four tertiary methyls, five methylenes and two quaternary
carbons. In HMBC analysis, the proton signal at dH 1.13
correlated with the carbons at dC 33.8 and 72.2, the proton
signals at dH 5.44 correlated with the carbons at dC 25.8 and
69.2, and the proton signals at dH 1.73 and 1.48 correlated
with the carbons at dC 146.0 and 72.2. In the
1H-1H COSY
spectrum, the signals at dH 1.73 and 1.48 correlated with dH
1.96 and 2.31, and dH 3.74 correlated with dH 5.44, indicating
the fragments of –CH2–CH2– and –CH–CH–. These corre-
lations revealed the presence of structural ring A. Moreover,
the HMBC correlations between dH 0.99 and dC 37.4, 44.3;
dH 1.02 and dC 51.4, 41.0, and 26.4; dH 2.17, 1.41 and dC
44.3, 41.0; and dH 0.79 and dC 51.4, 41.0, and 25.1 indicated
the presence of structural ring B. Furthermore, the proton
signals at dH 5.44 exhibited an HMBC correlation with
carbon dC 51.4, and dH 0.99 exhibited an HMBC correlation
with carbon dC 146.0, suggesting that structural rings A and
B were joined through carbons dC 146.0 and 51.4 (Fig. 4).
Based on this analysis, the structure of 11 was presumed to be
a cuparane-type sesquiterpenoid. The ROSEY spectrum
exhibited cross peaks between H-5/H-8b, H-8b/CH3-12,
H-1b/CH3-12, H-1a/CH3-14and H-4/CH3-15 (Fig. 4). A
detailed analysis of the chemical shifts and coupling con-
stants led to the determination of 3a,4a-dihydroxy-5-cupa-
rene as infuscol F (11).
Based on spectroscopic analyses and comparison with
the literature, the known compounds were identified as
sambucinol (3) [18], 3-deoxysambucinol (4) [18], trich-
othecolone (5) [19], trichodermol (6) [19], 8-deoxytricho-
thecin (7) [20], trichothecin (8) [19], trichothecinol B (9)
[8], trichothecinol A (10) [17], and cyclonerodiol (12) [21].
2.2 Effects of Compounds 1–10 on the Growth
of the HL-60, SMMC-7721, A549, MCF-7
and SW-480 Cell Lines
Compounds 1–10 were assayed for their cytotoxicity
against five human cancer cell lines (HL-60, SMMC-7721,
A549, MCF-7 and SW-480) using the MTT assay in vitro,
with cisplatin and taxol as the positive controls. The results
are shown in Table 2. Following a 48-h treatment, tricho-
dermol (6), 8-deoxytrichothecin (7), trichothecin (8),
trichothecinol B (9) and trichothecinol A (10) significantly
reduced the cell viabilities of these five cell lines, with IC50
values lower than 3.5 lM, suggesting that the inhibitory
effects of these compounds were more potent than those of
the positive control, cisplatin. In particular, trichothecinol
A (10) exhibited the strongest inhibitory effect on the
growth of HL-60, SMMC-7721, A549, MCF-7 and SW-
480 cells, with IC50 values of 0.022, 0.020, 0.015, 0.006,
and 0.011 lM, respectively, which was comparable to that
of the positive control, paclitaxel. Engleromycone B (2)
and trichothecolone (5) exhibited clear cytotoxic activity,
with IC50 values ranging from 2.7 to 21.13 lM. Engler-
omycone A (1) exhibited moderate cytotoxic activity, with
IC50 values ranging from 14.29 to 20.22 lM. Sambucinol
(3) and 3-deoxysambucinol (4) exhibited weaker cytotoxic
activity against these five cancer cell lines, with IC50 values
greater than 40 lM, and can be regarded as inactive.
2.3 Structure-Cytotoxicity Relationships
Trichothecin (8) exhibited stronger cytotoxicity than en-
gleromycone A (1), suggesting that an epoxide at C-12 and
C-13 increases the cytotoxicity. Moreover, trichothecinol
Table 2 Inhibitory effect of the isolated compounds against different
cancer cell lines
Compd. Cancer cell line IC50 (lM)
HL-60 SMMC-7721 A549 MCF-7 SW480
1 14.29 19.12 19.10 18.04 20.22
2 2.70 8.41 2.98 21.13 9.25
3 [40 [40 [40 [40 [40
4 [40 [40 [40 [40 [40
5 4.86 6.92 4.16 16.49 8.52
6 1.53 2.14 1.01 3.43 1.87
7 0.10 0.15 0.14 0.23 0.15
8 0.14 0.22 0.20 0.21 0.18
9 1.68 0.45 0.40 0.54 0.35
10 0.022 0.020 0.015 0.006 0.011
Cisplatin 1.91 5.81 6.43 13.26 11.99
Taxol \0.008 \0.008 \0.008 \0.008 \0.008
HO
HO
COSYH C HMBC H C ROSEY
BA
Fig. 4 Selected 2D NMR correlations of 11
50 Y. Wang et al.
123
A (10) exhibited greater potential cytotoxic activity than
that of trichothecin (8), indicating that the hydroxyl at C-3
increases the cytotoxic activity. Additionally, a comparison
between 8-deoxytrichothecin (7) and trichodermol (6) and
between trichothecin (8) and trichothecolone (5) indicated
that compounds with a –OCOCH=CHCH3 substituent at
C-4 (7 and 8) exhibited stronger cytotoxic activities than
those with a hydroxyl at C-4 (5 and 6). Finally, the dif-
ferences in the cytotoxic activities among 8-deoxytricho-
thecin (7), trichothecin (8) and trichothecinol B (9) were
small, indicating that alterations in the substituent at C-8 do
not effectively improve the cytotoxic activity.
2.4 Selective Cytotoxicities of the Trichothecenes
Against Cancer Cells
To investigate the selective cytotoxicities of the trichot-
hecenes, we chose A549 as the cancer cell line and BEAS-
2B as the normal cell line. The cytotoxicities of compounds
1, 2 and 5–10 were examined on these two cell lines using
the MTT assay. The results indicated that the cytotoxicities
of these compounds against the two cell lines were similar
(Table 3), suggesting that compounds 1, 2 and 5–10 did not
exhibit selective cytotoxicity against the A549 cell line.
In summary, three new and nine known sesquiterpenoids
were successfully isolated from the cultures of E. goetzii.
The biological studies indicated that compounds 1, 2 and
5–10 significantly reduced the viabilities of five human
cancer cell lines (HL-60, SMMC-7721, A549, MCF-7, and
SW-480). In particular, trichothecinol A (10) exhibited the
strongest inhibitory effect on the growth of MCF-7 cells,
with an IC50 value of 0.006 lM, which was comparable to
the cytotoxic activity of the positive control, paclitaxel.
These exciting results suggested that the trichothecene
analogs represent promising models for the design of new
anticancer agents. Therefore, we further investigated the
selective cytotoxicity of compounds 1, 2 and 5–10 against
cancer cells and normal cells. Although compounds 1, 2
and 5–10 did not exhibit selective cytotoxicities, additional
investigation to improve the selective cytotoxicities of
these trichothecenes would promote their use as a series of
potent anticancer agents.
3 Materials and Methods
3.1 General Experimental Procedures
The optical rotations were measured on a JASCO model
1020 polarimeter (JASCO International Co. Ltd., Tokyo,
Japan). The UV spectra were obtained on a Shimadzu
double-beam 2401A spectrophotometer (Shimadzu, Kyoto,
Japan). The IR spectra were recorded on a Bruker TEN-
SOR 27 FT-IR spectrometer (Bruker, Ettlingen, Germany)
with KBr pellets. The 1D and 2D NMR data were acquired
on Bruker AM-400, DRX-500 and AV-600 instruments at
room temperature (Bruker, Rheinstetten, Germany). The
chemical shifts (d) are expressed in ppm with reference to
the solvent signals. The mass spectra (MS) were obtained
on an API QSTAR time-of-flight mass spectrometer (MDS
Sciex, Ontario, Canada) or a VG Autospec-3000 spec-
trometer (VG, Manchester, England). Silica gel (200–300
mesh, Qingdao Marine Chemical Inc., Qingdao, China),
Sephadex LH-20 (Amersham Biosciences, Sweden), and
RP-18 gel (40–75 lM, Fuji Silysia Chemical Ltd., Japan)
were used for column chromatography. Preparative HPLC
(Prep-HPLC) was performed on an Agilent 1100 liquid
chromatography system equipped with a ZORBAX SB-
C18column (9.4 mm 9 150 mm). Precoated silica gel GF
254 plates (Qingdao Marine Chemical Inc., Qingdao,
China) were used for TLC analysis. The fractions were
monitored by TLC analysis, and the spots were visualized
under UV light (254 or 365 nm) or by heating silica gel
plates sprayed with 10 % H2SO4 in ethanol.
3.2 Fungal Material and Cultivation Conditions
The fungus E. goetzii was collected from bamboo groves of
Shangri-La County in Yunnan Province, China, in August
2012 and was identified by Prof. Zhu-Liang Yang (Kun-
ming Institute of Botany, Chinese Academy of Sciences).
A voucher specimen was deposited in the Herbarium of the
Kunming Institute of Botany of the Chinese Academy of
Sciences. The mycelial cultures were derived from the
tissue plugs. The culture PDA medium consisted of glucose
(5 %), peptone from porcine meat (0.15 %), yeast powder
(0.5 %), KH2PO4 (0.05 %) and MgSO4 (0.05 %). The
inoculums of E. goetzii were prepared in a 15-L fermenter
(Biostar, Shanghai Guoqiang, China) for 6 d under the
Table 3 Inhibitory effect of compounds 1, 2 and 5–10 against A-549
and BEAS-2B cell Lines
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following conditions: culture temperature, 24 C; initial
pH, 6.0; agitation speed, 250 r/min; inoculation volume,
10 % (by volume); and aeration rate, 1.0 volume/culture
volume/min. Subsequently, the liquid seed was transferred
into a 100-L fermentation tank for cultivation under iden-
tical conditions for 20 d to afford an 80-L culture broth.
3.3 Extraction and Isolation
The fermentation broth (80 L) was filtered, and the filtrate
was concentrated to 10 L under reduced pressure and then
extracted with ethyl acetate (3 9 10 L). The organic layer
was evaporated to yield a crude extract (350 g). Subse-
quently, the extract was subjected to silica gel column
chromatography using a petroleum ether/acetone gradient
system (100:0 ? 0:100 V/V) to afford fractions F1–F7
based on TLC analyses. F2 was purified using Sephadex
LH-20 column chromatography (chloroform/metha-
nol = 1:1 V/V) and then subjected to silica gel column
chromatography (petroleum ether/acetone = 150:1 V/V)
to afford compound 8 (2160 mg). F3 was fractionated using
Sephadex LH-20 column chromatography (chloroform/
methanol = 1:1 V/V) to yield two subfractions (F3–1 and
F3–2). F3–2 was subjected to silica gel column chromatog-
raphy using a petroleum ether/acetone system (100:1 V/V)
to yield F3–2–1 and F3–2–2. F3–2–2 was purified by pre-
parative HPLC (acetonitrile/water = 6:4 ? 9:1 V/V,
10 mL/min in 20 min) to afford compounds 2 (7.0 mg,
retention time (tR) = 11.2 min) and 7 (28.8 mg,
tR = 12.3 min). F4 was subjected to silica gel column
chromatography and eluted by chloroform/acetone
(150:1 V/V), followed by Sephadex LH-20 column chro-
matography (chloroform/methanol = 1:1 V/V) to afford
compound 4 (80.0 mg). F5 was separated using silica gel
column chromatography (chloroform/metha-
nol = 100:1 V/V) to yield two fractions (F5–1 and F5–2).
F5–1 was further purified using Sephadex LH-20 column
chromatography (chloroform/methanol = 1:1 V/V) to
afford compound 12 (40.9 mg). F5–2 was separated with
silica gel (chloroform/methanol = 150:1 V/V) and
Sephadex LH-20 (chloroform/methanol = 1:1 V/V) col-
umn chromatography to yield two subfractions (F5–2–1 and
F5–2–2). F5–2–1was separated by preparative HPLC (aceto-
nitrile/water = 2:8 ? 6:4 V/V, 10 mL/min in 25 min) to
afford compounds 1 (27.5 mg, tR = 16.5 min), 6 (2.6 mg,
tR = 6.5 min), 9 (36.3 mg, tR = 7.9 min) and 10 (14.3 mg,
tR = 9.5 min). F5–2–2 was purified by silica gel column
chromatography (chloroform/methanol = 100:1 V/V) to
afford compound 3 (18.2 mg). F6 was subjected to silica
gel column chromatography (chloroform/metha-
nol = 50:1 V/V), followed by Sephadex LH-20 column
chromatography (chloroform/methanol = 1:1 V/V) to
afford compound 5 (1426 mg). F7 was purified by
Sephadex LH-20 (chloroform/methanol = 1:1 V/V) and
RP-18 gel (methanol/water = 1:1 V/V) column chroma-
tography to afford compound 11 (0.8 mg).
3.4 Engleromycone A (1)
Colorless oil; a½ 22D ? 1.7 (c 0.18, MeOH); UV (MeOH):
kmax (log e) 372 (1.71), 212 (3.96) nm; IR (KBr): mmax
3472, 3457, 1719, 1686, 1645, 1171, 1046 cm-1; 1H and
13C NMR data see Table 1; ESI MS (positive) m/z 371
(100) [M ? Na]?; 349 (60) [M ? H]?; 719 (15)
[2M ? Na]?; HR ESI MS (positive) m/z 371.1,472
[M ? Na]? (calculated for C19H24O6Na, 371.1471).
3.5 Engleromycone B (2)
Colorless oil; a½ 22D ? 7.9 (c 0.2, MeOH); UV (MeOH):
kmax (log e) 211 (3.46) nm; IR (KBr): mmax 2984, 2940,
2926, 1713, 1650, 1437, 1415, 1181, 1026 cm-1; 1H and
13C NMR data see Table 1; ESI MS (positive) m/z 339 (30)
[M ? Na]?; 655 (10) [2M ? Na]?; HR ESI MS (positive)
m/z 339.1563 [M ? Na]? (calculated for C19H24O4Na,
339.1572).
3.6 Infuscol F (11)
Colorless oil; a½ 22D ? 46.3 (c 0.08, MeOH); UV (MeOH):
kmax (log e) 203 (3.97) nm; IR (KBr): mmax 3441, 3265, 2957,
2933, 2875, 1640, 1413 cm-1; 1H and 13C NMR data see
Table 4; ESI MS (positive) m/z 261 (100) [M ? Na]?; 499
(50) [2M ? Na]?; HR ESI MS (positive) m/z 261.1825
[M ? Na]? (calculated for C15H26O2Na, 261.1830).
3.7 Cytotoxicity Assays
The human tumor cell lines HL-60 (promyelocytic leuke-
mia), SMMC-7712 (hepatocarcinoma), A549 (lung carci-
noma), MCF-7 (breast adenocarcinoma), SW-480 (colon
adenocarcinoma) and BEAS-2B normal cell line (human
bronchial epithelial cell) were used. All of the cells were
cultured in RMPI-1640 or DMEM medium (HyClone,
Logan, UT, USA) plus 10 % fetal bovine serum (HyClone)
at 37 C in a humidified atmosphere with 5 % CO2. The
cytotoxicity assay was performed according to the MTT (3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide) method in 96-well microplates. Briefly, 100 lL of
adherent cells was seeded into each well of a 96-well cell
culture plate and allowed to adhere for 12 h prior to drug
addition, whereas the suspended cells were seeded imme-
diately prior to drug addition, both with an initial density of
1 9 105 cells/mL. Each tumor cell line was exposed to the
52 Y. Wang et al.
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test compounds at various concentrations in triplicate for
48 h, with cisplatin and paclitaxel as the positive controls.
Following incubation, MTT (100 lg) was added to each
well, and the incubation continued for 4 h at 37 C. The
cells were lysed with 200 lL of SDS following the removal
of 100 lL of the medium. The optical density of the lysate
was measured at 595 nm in a 96-well microtiter plate
reader (Bio-Rad 680). The IC50 value of each compound
was calculated using Reed and Muench’s method [22].
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